Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B1 (NDUFB1)

Target
NDUFB1
Molecular classification
Enzyme, Accessory subunit of mitochondrial complex I
01

Overview

NADH:ubiquinone oxidoreductase subunit B1 (NDUFB1) is a small protein (approx. 7 kDa, 58 amino acids) encoded by the NDUFB1 gene on chromosome 14[1]. This protein is an accessory, non-catalytic subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), a large enzyme complex in the mitochondrial inner membrane that is the first component of the electron transport chain[8][2]. NDUFB1 has a conserved L-shaped structure, anchoring complex I to the membrane through its hydrophobic domain and participating in interactions with other subunits through its hydrophilic domain[1]. While it is not directly involved in electron transfer catalysis, it contributes critically to the structural integrity, assembly, and function of complex I, ultimately supporting mitochondrial ATP production and energy metabolism[2][4][5]. Dysfunction or altered expression of NDUFB1 is associated with several diseases, especially those involving mitochondrial dysfunction, cancer, psychiatric, and metabolic disorders[1][2][5].

Other names
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1CI-MNLLMNLLCI-SGDHComplex I-MNLLNADH-ubiquinone oxidoreductase MNLL subunitcomplex I MNLL subunitNADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa
02

Biological functions

Mitochondrial electron transport (NADH to ubiquinone)Mitochondrial ATP synthesisAssembly of mitochondrial respiratory chain complex I
03

Disease associations

Mitochondrial diseaseType 1 diabetes mellitusType 2 diabetes mellitusSchizophreniaBreast cancerBipolar disorderUrinary bladder carcinomaProstate cancerBacterial gastritis
04

Safety considerations

Disruption may impair mitochondrial function and energy productionDysfunction may be involved in certain cancers and metabolic or neuropsychiatric diseases

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B1 (NDUFB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B1 (NDUFB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call